Breaking Finance News

Cello Group PLC (LON:CLL) target price held steady at 130.00GBX, reported today by Peel Hunt

Cello Group PLC (LON:CLL) had its target price hold steady to 130.00GBX by Peel Hunt in a report released 10/19/2016. The new target price indicates steady performance relative to the company's last stock close price.

Previously on Monday October 03, 2016, finnCap reported about Cello Group PLC (LON:CLL) held steady the target price at 132.00GBX. At the time, this indicated a possible upside of 0.24%.

Yesterday Cello Group PLC (LON:CLL) traded 0.49% higher at 0.00GBX. The company’s 50-day moving average is 106.32GBX and its 200-day moving average is 99.64GBX. The last stock close price is down 3.88% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 21,804 shares of the stock were exchanged, down from an average trading volume of 98,774

See Chart Below

Cello Group PLC (LON:CLL)

Cello Group PLC has a 52 week low of 77.10GBX and a 52 week high of 115.00GBX with a P/E ratio of 86.25 The company’s market cap is currently 0 GBX.

In addition to Peel Hunt reporting its target price, a total of 2 firms have reported on the stock. The consensus target price is 115.00GBX with 1 firm rating the stock a strong buy, 1 firm rating the stock a buy, 0 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.

About Cello Group PLC (LON:CLL)

Cello Group plc is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services principally to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States, Singapore and Hong Kong. The Company's subsidiaries include 2CV Limited, Cello Group Inc, Farm Communications Limited, Market Research International Limited and Insight Medical Research Limited.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.